Simaon HK, Winkle DA. 1997. Over-the-counter medications: Do parents give what they intend to give? Archives of Pediatrics and Adolescent Medicine 151(7):654–656.

Smalley W, Shatin D, Wysowski DK, Gurwitz J, Andrade SE, Goodman M, Chan KA, Platt R, Schech SD, Ray W. 2000. Contraindicated use of cisapride: Impact of Food and Drug Administration regulatory action. Journal of the American Medical Association 284(23):3036–3039.

Smetzer J. 2001. Safer medication management. Nursing Management 32(12):44–48.

Smetzer J, Cohen MR. 2006. Medication Error Reporting Systems in Medication Errors. 2nd ed. Washington, DC: American Pharmacists Association.

Smith PC, Araya-Guerra R, Bublitz C, Parnes B, Dickinson LM, Van Vorst R, Westfall JM, Pace WD. 2005. Missing clinical information during primary care visits. Journal of the American Medical Association 293(5):565–571.

Steinbrook R. 2004. Public registration of clinical trials. New England Journal of Medicine 351(4):315–317.

Strom BL. 2004. Potential conflict of interest in the evaluation of suspected adverse drug reactions. Journal of the American Medical Association 292(21):2643–2646.

Studdert DM, Mello MM, Brennan TA. 2004. Financial conflicts of interest in physicians’ relationships with the pharmaceutical industry: Self-regulation in the shadow of federal prosecution. New England Journal of Medicine 351(18):1891–1900.

Suzuki K, Ohida T, Kaneita Y, Yokoyama E, Uchiyama M. 2005. Daytime sleepiness, sleep habits and occupational accidents among hospital nurses. Journal of Advanced Nursing 52(4):445–453.

Svarstad BL, Bultman DC, Mount JK. 2004. Patient counseling provided in community pharmacies: Effects of state regulation, pharmacist age, and business. Journal of the American Pharmaceutical Association 44(1):22–29.

Szefler SJ, Whelan GJ, Leung DY. 2006. Black box warning: Wake-up call or overreaction? Journal of Allergy and Clinical Immunology 117(1):26–29.

Taira DA, Iwane KA, Chung RS. 2003. Prescription drugs: Elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. American Journal of Managed Care 9(4):305–312.

Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO. 1999. Noninvasive glucose monitoring: Comprehensive clinical results. Journal of the American Medical Association 282(19):1839–1844.

Teutsch SM, Berger ML, Weinstein MC. 2005. Comparative effectiveness: Asking the right questions, choosing the right method. Health Affairs 24(1):128–132.

Thomas CP. 2003. Incentive-based formularies. New England Journal of Medicine 349(23): 2186–2188.

Tokars JI, Richards C, Andrus M, Klevens M, Curtis A, Horan T, Jernigan J, Cardo D. 2004. The changing fact of surveillance for health care-associated infections. Clinical Infectious Diseases 39:1347–1352.

University of Utah. 2006. Chapter 1: Testing and Marketing: Drug Development. [Online]. Available at: [accessed June 5, 2006].

USP (U.S. Pharmacopeia). 2003. Summary of Information Submitted to MedMarx in the Year 2002. Rockville, MD: USP.

USP. 2004. MedMarx 5th Anniversary Data Report: A Chartbook of 2003 Findings and Trends 1999–2003. Rockville, MD: USP.

Vincent C. 2001. Clinical Risk Management: Enhancing Patient Safety. 2nd ed. London, UK: BMJ Books.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement